中国药房2016，Vol.27Issue(5)：577-580,4.DOI:10.6039/j.issn.1001-0408.2016.05.01
银丹心泰滴丸治疗冠心病心绞痛的成本-效益分析
Cost-benefit Analysis of Yindan Xintai Dropping Pills in the Treatment of Angina Pectoris Caused by Coro-nary Heart Disease
摘要
Abstract
OBJECTIVE:To evaluate the economics of Yindan xintai dropping pills in the treatment of angina pectoris caused by coronary heart disease from societal perspectives. METHODS:Therapy regimens related to Yindan xintai dropping pills and con-trol regimens were selected from published literatures included in database,and the cost of therapy regimens and clinical effect data were extracted from literatures. Contingent evaluation method was used to measure people's willingness-to-pay for angina pectoris treatments. An econometric model was conducted to transfer the effectiveness data to benefit data. The economics of treatment was evaluated depending upon net benefit or incremental net benefit indicator. RESULTS & CONCLUSIONS:When Yindan xintai drop-ping pills is used alone,its net benefit is >0,indicating economical advantage;56 d therapy regimen is better than 28 d therapy. When Yindan xintai dropping pills were combined with glyceryl trinitrate tablet,Isosorbide mononitrate sustained-release tablet, Simvastatin dispersible tablet and other drugs,its incremental net benefit is better than control regimens and has good economics.关键词
银丹心泰滴丸/冠心病心绞痛/成本-效益分析/条件价值评估法/净效益值/增量净效益值Key words
Yindan xintai dropping pills/Angina pectoris caused by coronary heart disease/Cost-benefit analysis/Contingent valuation method/Net benefit/Incremental net benefit分类
医药卫生引用本文复制引用
伍红艳,汤磊..银丹心泰滴丸治疗冠心病心绞痛的成本-效益分析[J].中国药房,2016,27(5):577-580,4.基金项目
国家自然科学基金资助项目(No.71463007) （No.71463007）
贵州省科技计划课题(No.黔科合SY字〔2013〕3068号) （No.黔科合SY字〔2013〕3068号）
